Open Now
Contact Information
401 North 17th Street Suite 308, Allentown, Pennsylvania 18104, United States
Detailed Information
PursueCare
-
Services:
- Outreach to persons in the community
- Complete medical history/physical exam
- Screening for tobacco use
- Comprehensive substance use assessment
- Screening for mental disorders
- Interim services for clients
- Comprehensive mental health assessment
- Screening for substance use
- Cash or self-payment
- Medicare
- Medicaid
- Private health insurance
- State-financed health insurance plan other than Medicaid
- Federal military insurance (e.g., TRICARE)
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- This facility administers/prescribes medication for alcohol use disorder
- Mental health services
- Case management service
- Suicide prevention services
- Sign language services for the deaf and hard of hearing
- Maintenance service with medically supervised withdrawal after stabilization
- Buprenorphine maintenance
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Prescribes naltrexone
- Sliding fee scale (fee is based on income and other factors)
- Drug and alcohol oral fluid testing
- Drug or alcohol urine screening
- Naloxone and overdose education
- Outcome follow-up after discharge
- Discharge Planning
- Aftercare/continuing care
- State Substance use treatment agency
- State department of health
- The Joint Commission
- Cognitive behavioral therapy
- Motivational interviewing
- Brief intervention
- Substance use disorder counseling
- Contingency management/motivational incentives
- Trauma-related counseling
- Matrix Model
- Relapse prevention
- Telemedicine/telehealth therapy
- Anger management
- Female
- Male
- Assistance with obtaining social services
- Housing services
- Self-help groups
- Mentoring/peer support
- Private for-profit organization
- Other contracted prescribing entity
- No formal relationship with prescribing entity
- In-network prescribing entity
- Outpatient
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- Adults
- Young Adults
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Pregnant/postpartum women
- Adult women
- Clients who have experienced trauma
- Adult men
- Naltrexone (oral)
- Disulfiram
- Clonidine
- Buprenorphine with naloxone
- Acamprosate (Campral®)
- Buprenorphine without naloxone
- Medication for mental disorders
- Non-nicotine smoking/tobacco cessation
- Naltrexone (extended-release, injectable)
- Nicotine replacement
- Smoking permitted in designated area
- Vaping permitted in designated area
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- Family counseling
- Smoking/vaping/tobacco cessation counseling
- Substance use disorder education
- Individual counseling
- Group counseling
Assessment/Pre-treatment
Payment/Insurance/Funding Accepted
Opioid Medications used in Treatment
Type of Alcohol Use Disorder Treatment
Ancillary Services
Language Services
Type of Opioid Treatment
Payment Assistance Available
Testing
Transitional Services
License/Certification/Accreditation
Treatment Approaches
Gender Accepted
Recovery Support Services
Facility Operation (e.g., Private, Public)
External Source of Medications Used for Alcohol Use Disorder Treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Age Groups Accepted
Type of Care
Special Programs/Groups Offered
Pharmacotherapies
Facility Smoking Policy
Facility Vaping Policy
Education and Counseling Services
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm